
#UnitreeIPOJumps629%
About UnitreeIPOJumps629%
Unitree Robotics opened ~629% higher on its trading debut, briefly topping CNY440B in value and nearing a 1,600x P/E on 2025 earnings. Pricing reflects humanoid mass-production hopes, scarcity of listed full-system makers and limited first-day float. Yet Q1 2026 net profit attributable to shareholders fell ~48% YoY, while demand still must translate into repeatable industrial use cases. Can shipment growth and adoption absorb the valuation, or was the debut mostly a scarcity premium?
Hot
Latest
UnitreeIPOJumps629% Popular posts
Pinned
After Changxin, Yushu Rises: The Value and Significance of the First Humanoid Robot Stock
On August 19, Unitree Technology (688836.SH) officially debuted on the Shanghai Stock Exchange STAR Market, turning the title of "the first humanoid robot stock in A-shares" from a name into reality. The opening price was 1100 yuan, up 629.44% from the issue price of 150.80 yuan, far exceeding the average first-day increase of 466.61% for new STAR Market stocks this year. Its market value once surged to 445 billion yuan. This A-share wealth creation feast of the year, which "only took 73 days to pass the review, had nearly 9.8 million subscription accounts, and an online winning rate of only 0.018%", saw a single lot profit of 475,000 yuan for 500 shares, far exceeding previous estimates and multiplying the principal by about 6.3 times. After the overseas SpaceX's "the largest IPO in human history" and the storage newcomer Changxin Technology's "domestic storage leader IPO", Unitree Technology took the capital stage as the "only profitable humanoid robot manufacturer" and was highly sought after right from the opening. As of the time of writing, Unitree Technology's stock price is around 892 yuan, with a market value of about 361 billion yuan, a turnover rate of 55.25%, and a trading volume exceeding 15.3 billion yuan. In the current era of rapid development in AI and hard technology, Unitree Technology's listing itself is one of the epitomes of the mainline trend in the capital market. Unitree Technology's value: the market's answer is 350-450 billion yuan. After the Unitree Technology IPO subscription ended, regarding the question of "reasonable market value range for Unitree Technology," I
#UnitreeIPOJumps629%
🤖 A ROBOT MAKER JUST OUT-PUMPED HALF OF CRYPTO
Unitree Robotics opened its Shanghai debut up 629% today. Not a typo.
Shares jumped from the ¥150.80 IPO price to ¥1,100 at the open — turning a ~$9B listing valuation into roughly $66B before some of the froth came off. Even after paring back to around ¥900, early buyers are still sitting on close to 5x gains from a single trading session.
The demand behind it was absurd: retail orders came in at more than 5,500x the available shares. Founder Wang Xingxing's stake alone briefly topped $12B. Meituan, an early backer, saw its position return over 70x.
Here's the part that separates this from pure hype: Unitree is actually profitable and shipped roughly 5,500 units last year. Backers include Tencent, Alibaba, and DeepSeek. As China's first publicly traded humanoid robot maker — in a country already producing the bulk of the world's humanoid robot supply — this listing is being watched as a signpost for how public markets will price "embodied AI" going forward.
The catch: a stock that can 6x in one session isn't exactly proof of efficient pricing. Viral backflip demos are one thing; getting robots reliably working warehouse floors at scale is another. More Chinese robotics IPOs are reportedly lining up to test whether the appetite holds.
Reflects publicly reported IPO data as of Aug 19, 2026. Not investment advice.
#XiaomiQ2Earnings #SandiskValuationSplit
$BTC $ETH $AI

1956. Egypt nationalised the Suez Canal and the world spent months arguing whether that stretch of water was actually worth what Nasser said it was worth.
Nobody had a real number until the ships stopped moving and the market was forced to price the chokepoint for real.
Unitree just did that to humanoid robots.
Nobody had a public benchmark for what a real, shipping, profitable humanoid company is worth. Analysts were guessing. Private markets were guessing. Then Unitree (688836) listed on Shanghai's STAR Market and the guessing stopped.
Stock opened up 629%. By midday it was still up 492.18%, near a $53.3 billion valuation, up from a $9.1 billion IPO price.
Read that again..
This company shipped 5,500 humanoid robots in 2025. Booked $252 million in revenue. Already profitable. That's not a pitch deck, that's a real business getting a real public price tag for the first time.
Now look at what that price does to everyone else on the board.
Agility Robotics, backed by Nvidia and Amazon, is going public through Churchill Capital Corp XI at a $2.5 billion pre-money valuation. Unitree just traded at more than 21 times that, for the same category of machine.
Tesla is worth over $1 trillion, but Optimus doesn't even have its own ticker. It's just a line item inside a car company.
Here's why today of all days matters.. every humanoid deal that was priced before this listing now has to explain why it isn't this expensive. Just like Suez in 1956, the number was never real until someone was forced to price it in public.
The system worked for someone today.. just not for the guy who priced his round last quarter.
Follow and turn on notifications before it's too late.

#UnitreeIPOJumps629% Unitree Robotics surged as much as 629% during its Shanghai STAR Market debut, opening at approximately RMB1,100 compared with an IPO price of RMB150.80. The Chinese humanoid-robot maker raised roughly RMB6.1 billion, or about $904 million, to fund advanced robotics research and expand manufacturing capacity. Unitree and AGIBOT reportedly each shipped more than 5,000 humanoid robots last year, putting them well ahead of many American competitors by production volume.
The debut demonstrates extraordinary investor enthusiasm for “embodied AI,” but it also creates serious valuation risk. Unitree’s IPO was already priced at more than 200 times earnings, and the first-day surge pushed the implied multiple dramatically higher. A limited public float likely intensified the move. Unitree has genuine technology and manufacturing advantages, yet investors must distinguish between leadership in an exciting industry and a price that assumes near-perfect execution. Future performance will depend on commercial demand, margins, production costs and whether humanoid robots move beyond demonstrations into repeatable industrial use.


🤖 UNITREE Opens 629% Above Its IPO Price
Unitree Robotics made a wild A-share debut today, opening at RMB 1,100 — 7.3× its RMB 150.80 IPO price.
For investors who won one 500-share IPO allotment, that meant roughly RMB 475K in paper gains at the open.
Humanoid robotics just hit the A-share market.
Long or short from here?
Trade UNITREE Perps on KuCoin Web3 Wallet 👇

#宇树科技科创板首日开盘暴涨629%,高估值如何兑现?
Market cap of 444.9 billion corresponds to 1.7 billion revenue in 2025, with a price-to-sales ratio exceeding 260 times. Yushi is not priced as "manufacturing," but as "infrastructure for the AI era."
Yushi Technology debuted on the STAR Market, opening at 1100 yuan/share, soaring 629.44% from the issue price of 150.80 yuan, with a market cap of 444.9 billion. It closed down to 845 yuan, market cap 341.8 billion, with a turnover rate as high as 85.28%. The issue P/E ratio is 219 times, nearly 6 times the average of 38 times for general equipment manufacturing.
How are the earnings? Revenue in 2025 is 1.699 billion, net profit 278 million. In the first half of 2026, revenue is 1.152 billion, a year-on-year increase of 48.54%, net profit 274 million. But Q1 non-recurring net profit is only 40.25 million, down 52.55% year-on-year. Nomura expects a compound revenue growth rate of 122% from 2026 to 2028, with revenue projected at 13.184 billion in 2028. R&D investment is nearly doubling, transitioning from "technology showcase" to "scale delivery."
A market cap of 340 billion based on current profits implies a dynamic P/E ratio of about 585 times. The market is truly betting not on the 1.7 billion revenue, but on the growth curve from "5,500 units → tens of thousands → hundreds of thousands." In 2025, humanoid robot shipments exceed 5,500 units, ranking first globally, but 73.6% of revenue comes from scientific research and education, with a very low share in industrial scenarios. The path from scientific research and education to factory workshops is still very long.
#宇树科技科创板首日开盘暴涨629%,高估值如何兑现?
The robot hasn't learned to work yet, but the market value has already soared
Today, Yushu Technology went public, opening at ¥1100, up 629%, with a total market value once reaching ¥444.9 billion. A single lot gained ¥470,000 paper profit.
But the real question is: why is a company with less than ¥1.7 billion revenue in 2025 worth over ¥300 billion?
The answer is betting on the future.
What are robots actually doing now? In 2025, humanoid robot revenue will be 73.6% from scientific research and education, with only 9% actually working in factories. Most robots are still being studied in labs and haven't truly entered factories to screw bolts.
There are also significant technical bottlenecks. General household robots will take at least another 3 to 5 years. Humanoid robots are the future, but not tomorrow.
A good company doesn't equal a good price. The first-day surge is driven by sentiment; whether it can hold long-term depends on whether robots can really start working in factories.
Snapshot at Aug 19, 2026, 21:32

629% Imagination Premium
On the first day of Yushi Technology's listing on the STAR Market, the stock surged 629%. This is not a numbers game; the market is voting with real money—betting on a narrative that has yet to fully unfold.
Quadruped robots are moving from the lab to mass production, and Yushi is the fastest on this path. But what does 629% mean? It means investors are not buying last year's revenue or this year's production capacity, but the imagination space for 2028, 2030, and even further. Humanoid robots entering factories, homes, and senior communities—each scenario is an uncut diamond.
The technical path is clear: motion control, perception systems, AI decision-making—all are in Yushi's reserves. But commercialization is never just a technical issue; it’s about cost, habits, and safety. How much would consumers be willing to pay for a robot that can serve tea and pour water? How long would the ROI be for replacing a factory worker? These numbers haven’t been finalized yet, but the stock price has already surged ahead.
The realization of a high valuation depends not on flashy videos at press conferences, but on real deliveries, real repurchases, and real reductions in failure rates. What Boston Dynamics struggled with for thirty years, Yushi aims to solve within three to five years—the capital market’s patience for time is shorter than a robot’s battery life.
629% is applause, but also a countdown. Under the spotlight, every step the robot takes is on a razor’s edge. #宇树科技科创板首日开盘暴涨629%,高估值如何兑现?
#宇树科技科创板首日开盘暴涨629%,高估值如何兑现?
Wow! The first humanoid robot stock made its debut today, causing chaos across the entire A-share market.
The issue price was only ¥150.8, but it soared directly to ¥1100 at the open, a 629% increase, pushing the market cap past ¥440 billion instantly.
However, the online winning rate was historically terrible at just 0.018%. The circulating shares are barely over 7%, with pitifully few chips, so once sentiment kicks in, it’s unstoppable. Scarce sector, AI hardware hype, retail investors rushing in like crazy—this is a classic case of telling a fantastic story first and proving real capability later.
The shareholder list is a blatant wealth show. Liang Wenfeng’s side, including DeepSeek, Illusion Square, and Nine Chapters, collectively hold over a million shares, with unrealized gains easily surpassing ¥1 billion at the open.
Lei Jun’s Shunwei group holds 16.1 million shares, with a paper gain exceeding ¥15 billion; Meituan is the largest external shareholder with 35.12 million shares, floating profits directly over ¥30 billion.
DJI missed out on a 2018 capital increase that could have brought in ¥25 billion at today’s opening price—rich people keep earning passively, while ordinary folks can’t even get a subscription. Reality is harsh.
But looking calmly, this valuation has already fully priced in an optimistic script for the next decade. The issue P/E ratio is 219x, dynamically soaring to nearly 700x, while the industry average is only about 38x.
The company’s revenue has grown from over ¥150 million to around ¥1.7 billion in recent years, with global humanoid robot shipments ranking near the top and gross margins reaching 60%, which looks solid.
However, profits after removing one-time gains dropped sharply in the first half of this year. They’re making more money but profits aren’t keeping pace—this is a clear problem.
The R&D investment over these years is just a small amount compared to the current market cap in the trillions, like a toy factory trying to support a big future story with a tiny budget.
Some professional analysts on X also think it’s completely unreasonable and all bubble, short on any rebound. Most clients are still university labs; less than 10% are actually working in factories. The core embodied large model is immature, and profits halved in Q1.
There are even comments saying they’re just a high-end toy factory dressed up in a tech coat. Three years of R&D total only a few tens of millions of USD, less than what toy giants spend in a year. The founder knows this well; expectations are ridiculously high, and it will be extremely hard to deliver.
To stabilize this sky-high valuation, they must grit their teeth and do three things: truly scale up industrial and commercial applications to fill the gap of revenue growth without profit growth; mass-produce humanoid robots, reduce costs, speed up updates, and stop relying on demo videos to fool people; and firmly maintain gross margins, or else it will just become a hollow shell sustained by financing burn.
If they fail, once the AI hardware hype fades, this ultra-high valuation will immediately become the prime target for everyone to sell off. The first day’s surge and drop already clearly signals disagreement among investors.
No matter how sexy the sector story is, performance ultimately speaks.
And it also depends on whether they can truly put the lab stuff to work in factories.
Snapshot at Aug 19, 2026, 16:01


